ENDRA Life Sciences (NDRA) EPS (Weighted Average and Diluted) (2023 - 2026)
ENDRA Life Sciences (NDRA) reported EPS (Weighted Average and Diluted) of -$1.09 for Q1 2026, up 41.4% year-over-year from -$0.77 in Q1 2025, and up 66.46% quarter-over-quarter from -$3.25 in Q4 2025.
ENDRA Life Sciences (NDRA) EPS (Weighted Average and Diluted) (2023 - 2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has 4 years of EPS (Weighted Average and Diluted) data on file, last reported at -$1.09 in Q1 2026.
- EPS (Weighted Average and Diluted) for Q1 2026 came in at -$1.09, up 41.4% year-over-year; the trailing twelve-month figure through Mar 2026 was -$8.3 (up 52.62% YoY), and the FY2025 annual result was -$8.93, up 84.32% from the prior year.
- EPS (Weighted Average and Diluted) rose to -$1.09 in Q1 2026 per NDRA's latest filing, from -$3.25 in the prior quarter.
- Over five years, EPS (Weighted Average and Diluted) peaked at $25.2 in Q4 2024 and troughed at -$401.41 in Q4 2023.
- A 4-year average of -$56.29 and a median of -$2.1 in 2025 frame the typical range for EPS (Weighted Average and Diluted).
- The sharpest annual moves came in 2024 and 2025: EPS (Weighted Average and Diluted) surged 106.28% in 2024, then tumbled 112.9% in 2025.
- A 4-year view of EPS (Weighted Average and Diluted) shows it stood at -$401.41 in 2023, then surged by 106.28% to $25.2 in 2024, then plunged by 112.9% to -$3.25 in 2025, then jumped by 66.46% to -$1.09 in 2026.
- Business Quant data shows NDRA's EPS (Weighted Average and Diluted) at -$1.09 in Q1 2026, -$3.25 in Q4 2025, and -$2.1 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | -0.87 |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 4.43 |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 1.45 |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 3.47 |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 1.20 |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 1.61 |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | -0.60 |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 0.87 |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 8.33 |
| 10 | ENDRA Life Sciences | 5.25 Mn | 4.90 Mn | - | -1.09 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.09 |
| Dec 31, 2025 | -3.25 |
| Sep 30, 2025 | -2.10 |
| Mar 31, 2025 | -1.86 |
| Dec 31, 2024 | 25.20 |
| Sep 30, 2024 | -9.54 |
| Dec 31, 2023 | -401.41 |